[1]
V. C. de Souza, R. de B. Silva, and C. Antunis, “INTERFERON I AS A THERAPEUTIC TARGET IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: USE OF MONOCLONAL ANTIBODIES ANIFROLUMAB, RONTALIZUMAB AND SIFALIMUMAB”, REASE, vol. 9, no. 1, pp. 717–731, Jan. 2023, doi: 10.51891/rease.v9i1.8303.